AUSTRAL Dx

AUSTRAL Dx is a Paris-based company founded in 2021 that specializes in developing a novel imaging technique utilizing airborne ultrasound technology. This innovative approach aims to map the vibrations produced by the lungs, facilitating the screening, diagnosis, and monitoring of both cardiac and pulmonary conditions in various clinical settings, including emergency situations. By focusing on acute and chronic pathologies, AUSTRAL Dx enhances the efficiency of diagnosing patients exhibiting symptoms such as dyspnea or chest pain, thereby enabling healthcare professionals to improve patient outcomes through timely and accurate assessments.